Evidence map›Paper›PMID 34885071›Full record

ReviewCancers2021

Primary Skull Base Chondrosarcomas: A Systematic Review.

Paolo Palmisciano, Ali S Haider, Mohammadmahdi Sabahi, Chibueze D Nwagwu, Othman Bin Alamer, Gianluca Scalia, Giuseppe E Umana, Aaron A Cohen-Gadol, Tarek Y El Ahmadieh, Kenny Yu and 1 more

Open access · goldAbstract readReview
In one paragraph

Review in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 4 pooled it
7.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 4 syntheses or guidelines pooled it, 51 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Sinonasal Sarcomas Management: An International Consensus Statement.International forum of allergy & rhinology · 2026
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Surgical management of chondrosarcomas of the skull-base and temporal bone.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2024
    Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 9 institutions in 5 countries.

Paolo PalmiscianoDepartment of Neurosurgery, Trauma Center, Gamma Knife Center, Cannizzaro Hospital, 95126 Catania, Italy.ORCID 0000-0003-0711-3975
Ali S HaiderTexas A&M University College of Medicine, Houston, TX 77030, USA.
Mohammadmahdi SabahiNeurosurgery Research Group (NRG), Student Research Committee, Hamadan University of Medical Sciences, Hamadan 65141, Iran.ORCID 0000-0003-4640-226X
Chibueze D NwagwuEmory University School of Medicine, Atlanta, GA 30322, USA.
Othman Bin AlamerDepartment of Neurosurgery, King Abdullah International Medical Research Center, Riyadh 11451, Saudi Arabia.ORCID 0000-0001-9365-4115
Gianluca ScaliaDepartment of Neurosurgery, Highly Specialized Hospital of National Importance "Garibaldi", 95126 Catania, Italy.ORCID 0000-0002-9465-2506
Giuseppe E UmanaDepartment of Neurosurgery, Trauma Center, Gamma Knife Center, Cannizzaro Hospital, 95126 Catania, Italy.ORCID 0000-0002-1573-431X
Aaron A Cohen-GadolDepartment of Neurological Surgery, Indiana University School of Medicine, Indianapolis, IN 46077, USA.ORCID 0000-0002-4946-1524
Tarek Y El AhmadiehDepartment of Neurosurgery and Brain Metastasis Center, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.ORCID 0000-0002-7122-4349
Kenny YuDepartment of Neurosurgery and Brain Metastasis Center, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Omar N PathmanabanManchester Skull Base Unit, Department of Neurosurgery, Manchester Centre for Clinical Neurosciences, Geoffrey Jefferson Brain Research Centre, Salford Royal Hospital, Manchester Academic Health Science Centre, University of Manchester, Manchester M13 9WL, UK.ORCID 0000-0002-5083-9416
Memorial Sloan Kettering Cancer Center · USOspedale Cannizzaro · ITEmory University · USHamedan University of Medical Sciences · IRKing Abdullah International Medical Research Center · SAManchester Academic Health Science Centre · GBNeurological Surgery · USOspedale Garibaldi · ITTexas A&M University · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

backgroundPrimary skull base chondrosarcomas (SBCs) can severely affect patients' quality of life. Surgical-resection and radiotherapy are feasible but may cause debilitating complications. We systematically reviewed the literature on primary SBCs.

methodsPubMed, EMBASE, Scopus, Web-of-Science, and Cochrane were searched following the PRISMA guidelines to include studies of patients with primary SBCs. Clinical characteristics, management strategies, and treatment outcomes were analyzed.

resultsWe included 33 studies comprising 1307 patients. Primary SBCs mostly involved the middle-fossa (72.7%), infiltrating the cavernous-sinus in 42.4% of patients. Cranial-neuropathies were reported in 810 patients (62%). Surgical-resection (93.3%) was preferred over biopsy (6.6%). The most frequent open surgical approaches were frontotemporal-orbitozygomatic (17.6%) and pterional (11.9%), and 111 patients (21.3%) underwent endoscopic-endonasal resection. Post-surgical cerebrospinal-fluid leaks occurred in 36 patients (6.5%). Radiotherapy was delivered in 1018 patients (77.9%): photon-based (41.4%), proton-based (64.2%), and carbon-based (13.1%). Severe post-radiotherapy complications, mostly hypopituitarism (15.4%) and hearing loss (7.1%) were experienced by 251 patients (30.7%). Post-treatment symptom-improvement (46.7%) and reduced/stable tumor volumes (85.4%) showed no differences based on radiotherapy-protocols (

conclusionSurgical-resection and radiotherapy are effective treatments in primary SBCs, with acceptable complication rates and favorable local tumor control.

Indexed as

chondrosarcomaendoscopyradiation oncologyskull base oncologysystematic review

Identifiers

PMID34885071
PMCPMC8656924
OpenAlexW3217776450

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.